NCT02172443View on ClinicalTrials.gov

Comparison of Tiotropium Inhalation Capsules and Atrovent Metered Dose Inhaler (MDI) in a Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 2001

Primary Completion Date

May 31, 2002

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

tiotropium inhalation powder capsules

DRUG

Atrovent

DRUG

placebo to Atrovent

DRUG

placebo to tiotropium inhalation capsules

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02172443 - Comparison of Tiotropium Inhalation Capsules and Atrovent Metered Dose Inhaler (MDI) in a Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary Disease | Biotech Hunter | Biotech Hunter